Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure

Clinical trial NCT07038356 · RECRUITING

Trial details

NCT number: NCT07038356
Sponsor: Christian Schulze
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Decompensated Heart Failure (ADHF)

Start date: 2025-12-08
Primary completion: 2027-04-30
Enrollment: 536

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.